Foamix Pharmaceuticals Ltd. Proceeds from Stock Options Exercised
Foamix Pharmaceuticals Ltd. reported Proceeds from Stock Options Exercised of $365.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for the quarter ending 2019-12-31 was $311.00K, a 7675.00% increase year-over-year.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for the quarter ending 2019-09-30 was $36.00K, a 9.09% increase year-over-year.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for the quarter ending 2019-06-30 was $2.00K.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for the quarter ending 2019-03-31 was $16.00K.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for fiscal 2019 was $365.00K, a 676.60% increase from fiscal 2018.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for fiscal 2018 was $47.00K, a 70.81% decline from fiscal 2017.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for fiscal 2017 was $161.00K, a 43.75% increase from fiscal 2016.
- Foamix Pharmaceuticals Ltd. proceeds from stock options exercised for fiscal 2016 was $112.00K, a 67.44% decline from fiscal 2015.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2019-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $347.00K derived: sum of 2 quarters · filed 2020-03-12 | $349.00K derived: sum of 3 quarters · filed 2020-03-12 | $365.00K 10-K · filed 2020-03-12 |
| 2019-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $38.00K derived: sum of 2 quarters · filed 2019-11-12 | $54.00K 10-Q · filed 2019-11-12 | $58.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $18.00K 10-Q · filed 2019-08-07 | $22.00K derived: sum of 3 quarters · filed 2020-03-12 | $55.00K derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | $16.00K 10-Q · filed 2019-05-07 | $20.00K derived: sum of 2 quarters · filed 2020-03-12 | $53.00K derived: sum of 3 quarters · filed 2020-03-12 | |
| 2018-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $37.00K derived: sum of 2 quarters · filed 2020-03-12 | $47.00K 10-K · filed 2020-03-12 | |
| 2018-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $43.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $10.00K 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $16.00K derived: sum of 2 quarters · filed 2020-03-12 | $24.00K derived: sum of 3 quarters · filed 2020-03-12 | $161.00K 10-K · filed 2020-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.00K derived: sum of 2 quarters · filed 2018-11-07 | $145.00K 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $145.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $137.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $112.00K 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $344.00K 10-K · filed 2018-03-01 | |||
| 2015-06-30 | $315.00K 6-K · filed 2016-08-10 |